Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors. (Record no. 30131668)

MARC details
000 -LEADER
fixed length control field 02283 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518061806.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1476-5594
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/s41388-019-1012-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name O'Connor, Caitlin M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200619
245 00 - TITLE STATEMENT
Title Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Oncogene
Date of publication, distribution, etc. 01 2020
300 ## - PHYSICAL DESCRIPTION
Extent 703-717 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amino Acid Substitution
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arginine
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Calmodulin-Binding Proteins
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinogenesis
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element MAP Kinase Signaling System
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Membrane Proteins
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mitogen-Activated Protein Kinase Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Dynamics Simulation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutagenesis, Site-Directed
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nerve Tissue Proteins
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Phosphatase 2
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Transfection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tyrosine
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Xenograft Model Antitumor Assays
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leonard, Daniel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wiredja, Danica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Avelar, Rita A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Zhizhi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schlatzer, Daniela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bryson, Benjamin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tokala, Eesha
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Taylor, Sarah E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Upadhyay, Aditya
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sangodkar, Jaya
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gingras, Anne-Claude
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Westermarck, Jukka
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xu, Wenqing
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name DiFeo, Analisa
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brautigan, David L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Haider, Shozeb
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jackson, Mark
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Narla, Goutham
773 0# - HOST ITEM ENTRY
Title Oncogene
Related parts vol. 39
-- no. 3
-- p. 703-717
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/s41388-019-1012-2">https://doi.org/10.1038/s41388-019-1012-2</a>
Public note Available from publisher's website

No items available.